PRN: CPhI Japan Returns to Tokyo for 2012

CPhI Japan Returns to Tokyo for 2012 [07-March-2012] AMSTERDAM, March 7, 2012 /PRNewswire/ -- Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced that CPhI Japan will return to its traditional March timeslot in Tokyo for 2012. In 2011, CPhI Japan was held on a smaller scale in Osaka, Japan to accommodate the aftermath of the Northern Japan earthquakes.

Persone Greg Kerwin, May, June, August
Luoghi Europa, Giappone, Cina, America del Sud, India, Spagna, Indonesia, Shanghai, Mumbai, Amsterdam, Filadelfia, Pennsylvania, Asia Sudorientale, Stati Uniti d'America, Tokyo-to, Osaka-fu, Northern Province, Departement du Centre
Organizzazioni Company Codes, London Stock Exchange
Argomenti commercio, internet, chimica, musica

07/mar/2012 21.42.06 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

CPhI Japan Returns to Tokyo for 2012

 
[07-March-2012]
 

AMSTERDAM, March 7, 2012 /PRNewswire/ --

Leading events organiser UBM Live, a division of UBM Plc (LSE: UBM), today announced that CPhI Japan will return to its traditional March timeslot in Tokyo for 2012.  In 2011, CPhI Japan was held on a smaller scale in Osaka, Japan to accommodate the aftermath of the Northern Japan earthquakes. After taking time to stabilize, Tokyo will once again play host to CPhI Japan. The pharmaceutical ingredients event will run from 21-23 March, 2012 at the Tokyo Big Sight Exhibition Centre along with co-located events ICSE Japan for outsourcing solutions, P-MEC Japan for pharma machinery and technology, Pharmatech for drug packaging and delivery technology and the BioPh Pavilion for the biotechnology sector. The events are expected to return to full scale with projections for over 14,0! 00 attendees and more than 450 specialised global industry suppliers featured.

There are both new and returning developments to the events line-up in Tokyo. The BioPh Pavilion has been expanded to showcase the latest materials, technologies and services for the development of biotech-based drugs. A returning programme of sessions and workshops includes more than 120 conference and seminar sessions being held within the exhibition halls over the three days. The onsite location of the complementary programme guarantees convenience for those who attend.

"It is an important time for the pharma portfolio to return to Tokyo at full scale. Japan is focused on future growth and the events offer an unparalleled opportunity to network within this expanding Pharma market," said Greg Kerwin, Pharma Portfolio Director. He further noted, "The Japan Pharma events have closely mirrored the developments in this market through their own steady growth.  The Japanese government has been investing in infrastructure development, such as bioindustrial cluster projects and supporting programmes, in order to boost the sector. As Japanese Pharma manufacturers are catching up with their competitors in the US and Europe within the bio field, the country is projected to continue gaining importance as key player in the global Pharma industry."

The generics sector is one area of the pharma market that is experiencing significant growth in Japan. Generics are expected to increase their market share through sales from 8.3% in 2010 to 12.8% in 2015. This is an increase of more than 50% in just five years and the total generics market in Japan is predicted to be worth US$12.3 billion by that time, as well.(1) This presents significant opportunities for attendees of the events to increase their business within the Japanese Pharma market while it is at the early stages of a significant growth curve.

CPhI Japan caters to the preferred Japanese business values of face-to-face contact and consistency in business relationships. As the largest pharma ingredients event in the country, CPhI Japan provides an invaluable opportunity to meet in person and continue to build relationships, whether existing or new. CPhI Japan and co-located events also offer exhibitors an environment to directly establish recognition within the Japanese local business community while expanding professional networks and developing long-term relationships between suppliers and customers.

For more information about CPhI Japan and the co-located events, please visit http://www.cphijapan.com

UBM's market leading schedule of annual pharma events also includes South East Asia (10-12 May, 2012, Jakarta International Expo, Indonesia), ICSE USA (22-23 May, 2012, Pennsylvania Convention Centre, Philadelphia), China (26-28 June, 2012, SNIEC, Shanghai, China), South America (21-23 August, 2012, Transamerica Expo Centre, Brazil), Worldwide (9-11 October, 2012 at the Feria de Madrid, Spain) and India (21-23 November, 2012 at the Bombay Exhibition Centre in Mumbai, India).

(1) http://www.marketresearch.com/Business-Monitor-International-v304/Japan-Pharmaceuticals-Healthcare-Q2-6190108/

Notes for Editors:

UBM Live is a division of UBM Plc (LSE: UBM) a leading provider of business information services to the maritime, travel, fashion, technology, healthcare, media, and property industries. UBM offers services in trade shows, online, news distribution, and publishing to customers across the globe. Its brands are represented in more than 30 countries and are organized into specialist teams that serve their business communities helping them excel in their market by working effectively and efficiently. For more information, go to http://www.ubmlive.com.


Company Codes: LSE:UBM, Bloomberg:UBM@LN, RICS:UBM.L
blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl